(Q43462235)

English

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults

scientific article published in August 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

bacterial community

1 reference

based on heuristic

inferred from title

4

object named as

Javier Garau

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Patrick Petitpretz

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Christian Chidiac

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Francisco Soriano

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Katharine Stevenson

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Elisabeth Rouffiac

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

556 Clinical Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

119-129

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The hidden impact of antibacterial resistance in respiratory tract infection. Clinical failures: the tip of the iceberg?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical considerations and guidelines for the management of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Lower Respiratory Tract Infection Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900126-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(02)00126-7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43462235&oldid=2238478992"